✦ LIBER ✦

Second-line everolimus treatment in advanced renal-cell cancer

✍ Scribed by Vicki Brower

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN101 Cost Effectiveness of Everolimus

✍ J. Mihajlović; P. Pechlivanoglou; A. Sabo; Z. Tomić; M.J. Postma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCN74 Economic Evaluation of Everolimus

✍ Nevarez-Sida, A.; Fuentes-Alburo, A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-Effectiveness of Everolimus for Sec

✍ Mihajlović, Jovan; Pechlivanoglou, Petros; Sabo, Ana; Tomić, Zdenko; Postma, Maa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Axitinib and sorafenib in second-line tr

✍ Jame Abraham 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 85 KB

Second-line treatment options in advance

✍ Filippo de Marinis; Serena Ricciardi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Therapeutic Advances in Second-Line Trea

✍ Philip D. Bonomi 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 141 KB